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Abstract: In the last decade, high-performance liquid chromatography/tandem mass spectrometry
(LC/MS/MS) combined with electrospray ionization (ESI) has been widely used for determining low
concentrations of steroids, and derivatization has often been employed to enhance detection. In the
present study, endogenous steroidswere extracted using a Strata-XL polymeric reverse phase cartridge.
The isolated steroids were reacted with 2-hydrazino-1-methylpyridine (HMP) at 50 ◦C for 30 min.
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used in a positive mode
with multiple reaction monitoring (MRM) for the quantification of testosterone (T) and its precursor,
dehydroepiandrosterone (DHEA), in saliva samples collected from twenty young Saudi professional
soccer players. The analytes were separated on an ACE Ultracore 2.5 Superphenylhexyl column
(150 × 3.0 mm id). The extraction recovery during the pre-treatment was >89% and gave <±20% for
inter- and intra-assay precision and accuracy. The limits of quantification (LOQ) were found to be
20 pg/mL for (T and DHEA) and 50 pg/mL for Epitestosterone (EPI). The results showed no significant
variation in the concentration of T between pre and post training, whereas DHEA was significantly
increased after short-term exercise. These results could indicate that there is no correlation between T
and its precursor DHEA level following short term physical activity. EPI concentrations could not be
detected with a LOQ of 50 pg/mL in the saliva samples.
Keywords: testosterone; dehydroepiandrosterone; epitestosterone; 2-hydrazino-1-methylpyridine;
liquid chromatography; mass spectrometry
1. Introduction
Testosterone (T) is a primary androgen hormone and an anabolic steroid that is secreted by the
testicles of males and the ovaries of females. It stimulates the development of male characteristics by
binding to androgen receptors to exert its action [1]. Dehydroepiandrosterone (DHEA) is the precursor
of testosterone and other steroids and is produced by the adrenal glands [2]. Epitestosterone (EPI)
is an inactive 17 alpha-epimer of testosterone [3]. A correlation between T and DHEA in biological
samples has not been confirmed. Some diseases may be related to decreased levels of DHEA in serum,
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such as depression, osteoporosis and the metabolic syndrome [4]. However, it is not clear whether
these diseases are the consequence of a decline in DHEA itself, resulting from metabolic products of
DHEA, such as T [4,5].
Previous studies focused on the correlation between DHEA in saliva (Sal-DHEA) and serum
samples. For example, in a study that was conducted in the Korean population, a radioimmunoassay
(RIA) was used, demonstrating a positive correlation between the levels of DHEA in saliva and serum;
additionally, there is an inverse variation in its level with age (n = 167 in men, n = 192 in women
between 21–69 years) [6]. Another study investigated the correlation between T in saliva (Sal-T) and
serum (Serum-T) samples, finding a positive correlation in men between the T level in saliva and serum
(n = 104). However, there was no clear relationship of the T level in women between the saliva and
serum (n = 91) [7]. Unlike serum-T, Sal-T is generally referred to as a free active steroid because of its
association with the level of unbound T in serum, which is less than 2% of the circulating T [8]. By using
LC-MS/MS, a Japanese group compared Sal-T and Sal-DHEA levels (n = 114), showing a low correlation
between them. A variation in the activity of one or both enzymes, 3β-hydroxysteroid dehydrogenase
(HSD) and 17 β -HSD, which are responsible for the conversion of DHEA to T, may control the ratio
between them [9].
A recent study conducted in 2017 on a large British general population of men (n = 1675) aged
between 18 and 69 years, and women (n = 2453) aged between 18 and 74 years, for the detection of
Sal-T, used LC-MS/MS. The study showed an association between increased age and a reduction in the
mean Sal-T level, since the annual average decline was between 1% and 1.4% in men and 1.3% and
1.5% in women [10].
There has been a debate regarding the effects of physical activity on the level of Sal-T in
sports players. Previous research showed that the effects were varied among professional players.
Concentrations were increased in soccer players aged 10–16 years old by activity, whereas the level
was unchanged in rugby players aged 25 years [11,12]. In 2018, Australian researchers highlighted
a correlation of the subsequent performance and the period of the former training load and fatigue
response with the playing positions of 23 A-league football players. Regarding the impact of the
training load on Sal-T, testosterone was increased for both short and long periods of training (3 to 28
days). Although the Sal-T level increased in both periods, the performance improved only for the
majority of midfielders [13].
EPI is still under investigation regarding its metabolism and physiology. It is not produced from
testosterone. [14]. To date, T and EPI can be detected only in urine. Athletes are suspected of androgen
abuse if the ratio of T/EPI in urine is >4 [15]. Nawed et al. were for the first time able to determine
T and EPI in human hair using LC-MS/MS. They reported that the correlation between the average
T/EPI ratio was linear [16]. A study conducted in 2014 detected EPI in rat serum, which indicated the
possibility of detecting it in human saliva [17].
Researchers have used several techniques to measure androgens in body fluids, hair and tissues,
such as high-performance liquid chromatography (HPLC) and gas chromatography-mass spectrometry
(GC-MS) [18,19]. In the last decade, liquid chromatography (LC) combined with mass spectrometry
(MS) was introduced in various studies, resulting in a reduced analysis time and increased sensitivity
in determining low concentrations of androgens [16,17,20–22]. Only one previous study reported the
detection of T and DHEA in saliva by using LC-MS/MS, as shown in Table 1; many studies have used
a radio-immunoassay.
Because some neutral steroids with low concentrations in saliva samples are particularly
challenging to ionize in the ion source, chemical derivatization can be used to optimize the sensitivity
for detecting analytes in saliva using ESI-MS [22–24]. In 2004, Higashi et al. reported that,
when comparing the derivatization reagent 2-Hydrazino-1-methylpyridine derivative (HMP) with
2-fluoro-1-methylpyridine (FMP) and Girard’s reagent P (GP), the HMP reagent yielded the best results
with DHEA. The detectability of the DHEA-HMP was 1600 > underivatized DHEA in ESI [22,25,26].
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Table 1. Comparison of the present method with previously reported methods of detection of T and DHEA in the saliva sample.
Author, Year (Ref.) Analyte Instrument
Collection
Method
Extraction Derivative Chromatography LOQ Case Samples
Granger et al.,1999 [2] DHEA radioimmunoassay directly
64 (8–11 y) 96 (12–17 y) 48
(30–45 y)
Ostatníková et al., 2002 [27] T radioimmunoassay directly 77 girls & 126 boys (6–9 y)
Morley et al., 2006 [28] T radioimmunoassay directly 1454 (20–89 y) male
Ahu et al. 2007 [6]
Cortisol and
DHEA
radioimmunoassay directly
359 (21–96 y) male
&female
Higashi et al., 2007 [5] DHEA LC–ESI-MS–MS directly SPE Strata-X (ethyl acetate) *
(HMP) incubation
(60 ◦C for 1 h)
ODS-H-80 column (10 µL
injected)
25 pg/mL
3 (33–23 y) male 3 (22–24
y) female
Beaven et al., 2008 [12]
Cortisol and
T
immunoassay Directly 23 men rugby players
Yasuda., 2008 [29] T LC-MS and ELISA directly LLE (ethyl acetate) CD-C18 column 51 (30–85 y) 29 (55–78 y)
Shibayamaet al.,2009 [9]
DHEA and
T
LC–ESI-MS–MS directly SPE Strata-X (ethyl acetate) *
(HMP) incubation
(60 ◦C for 1 h)
AYMC-Pack Pro C18 RS
column (10 µL injected)
10 pg/mL 114 (21–89 y)
Cardoso et al.,2010 [30] T radioimmunoassay directly 60 (20–60 y) male
Macdonald et al., 2011 [31] T LC-MS/MS directly LLE (methyl-tert-butyl ether) C18 column 7 pg/mL 103 (16–74 y) male
Keevil et al., 2014 [7] T LC-MS/MS directly LLE (methyl-tert-butyl ether) *
C8 column (35 µL
injected)
1.5 pg/mL 104 males 91 females
Maya et al., 2016 [32]
Cortisol and
T
ELISA directly
16 (22.5 ± 2.1 y) female
players
Clifton et al., 2016 [33] T LC-MS/MS directly LLE (methyl-tert-butyl ether) *
C8 column (35 µL
injected)
1.8 pg/mL
1599 male 2123 female
(18–74 y)
Büttler et al., 2016 [23] T LC-MS/MS directly
(SPE) Symbiosis online solid
phase extraction
methoxylamine
hydrochloride
LOD 1.3 pg/mL
131 girls and 123 boys
(8–26 y)
Keevil et al., 2017 [10] T LC-MS/MS directly LLE (methyl-tert-butyl ether) *
C8 column (35 µL
injected)
1.5 pg/mL 1675 male 2453 female
Rowell et al., 2018 [13]
Cortisol and
T
ELISA directly
23 (23 ± 4.1 y) Football
player
This study
DHEA and
T
LC-MS/MS
Salivette
Polyester
(SPE) Strata-XL polymeric
reverse phase (ACN) *
(HMP) incubation
(50 ◦C for 30 min)
Ultracore 2.5
Superphenylhexyl
column (10 µL injected)
20 pg/mL
20 (20.6± 1.4 y) male
football players
Abbreviation: (*) Elution solvent, (y) Years old. (T) Testosterone, (DHEA) Dehydroepiandrosterone, (HMP) 2-Hydrazino-1-methylpyridine, (ACN) Acetonitrile, (LOD & LOQ) lower limit
of detection & quantification, (LC-ESI-MS) liquid chromatography electrospray ionization mass spectrometry, (SPE) Solid phase extraction and (LLE) liquid-liquid extraction.
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The current work follows the previous work by Higashi et al. [22]. The first aim of this study
was to develop a sample preparation method and derivatization using HMP (Figure S1) to detect
testosterone, dehydroepiandrosterone and epitestosterone in saliva samples using LC-ESI-MS/MS.
The secondary target was to apply the validated method to the analysis of saliva samples collected
from 20 young professional soccer players pre- and post-training on two separate days.
2. Materials and Methods
2.1. Chemicals and Materials
The following reagents were purchased from Sigma-Aldrich, UK:
2-fluoro-1-methylpyridinium-p-toluenesulfonate, hydrazine hydrate, testosterone (T),
dehydroepiandrosterone (DHEA), epitestosterone (EPI), deuterated testosterone (T-d3), trifluoroacetic
acid (TFA), methanol (MeOH), ethanol (EtOH). HPLC grade water, HPLC grade acetonitrile (ACN)
and HPLC grade ethyl acetate were purchased from Fisher Scientific, UK. HPLC grade formic acid
(98%) was obtained from BDH-Merck, UK. Individual stock solutions of T, DHEA, EPI and T-d3 were
prepared in EtOH at 10 µg/mL, each followed by dilution to prepare 1 µg/mL, 10 and 1 ng/mL of
working solutions in EtOH.
2.2. Preparation of 2-Hydrazino-1-Methylpyridine Derivative (HMP)
HMP was synthesized according to the work of Higashi et al. [22] as follows: hydrazine hydrate
solution (80%, 132 µL) inMeCN (30mL)was added to 2-fluoro-1-methylpyridinium-p-toluenesulfonate
(FMP-TS) (300 mg) in MeCN (6 mL) at 0 ◦C after stirring for 10 min at 0 ◦C and then maintained for
20 min at room temperature under N2. The residue was dissolved for a second time in MeCN (2 mL)
after this resulting mixture was concentrated. Following this, it was filtered, and the crude product was
recrystallized (twice) from MeCN–ethyl acetate (5:1, v/v) to give HMP (98 mg) as colourless needles
(m.p.: 133–134 ◦C; ESI-MS: m/z 124.3 [M]+). Finally, HMP was stored at 4 ◦C; this product remained
stable for at least six months.
2.3. Instrumentation
An Agilent liquid chromatography–mass spectrometry (LC-MS-MS) triple, quadruple G6430A
mass spectrometer equipped with an Agilent 1200 series auto-sampler, a quaternary pump SL with a
degasser, and a thermostatic column compartment was used for the quantitative analysis. Positive
electrospray ionization (+ESI) was used, and the mass spectrometry (MS) was operated in the multiple
reaction monitoring mode (MRM). The data were recorded using Mass Hunter software version B.06.00
(Agilent technologies).
2.3.1. Liquid Chromatographic Conditions
The analytes were separated on an ACE Ultracore 2.5 Superphenylhexyl column (150 × 3.0 mm
id) with a guard column, and the temperature was maintained at 30 ◦C. Isocratic elution was carried
out with water: acetonitrile (75:25), containing 0.01% (formic acid) FA with a flow rate of 0.4 mL/min.
The injection volume and run time were 10 µL and 16 min, respectively.
2.3.2. Mass Spectrometric Conditions
The androgens and testosterone-d3 (T-d3) derivatized with 2-Hydrazino-1-Methylpyridine
Derivative HMP were quantified by using an Agilent liquid chromatography–mass spectrometry
(LC-MS-MS) triple quadrupole G6430A mass spectrometer. The multiple reaction monitoring (MRM)
conditions were examined by injecting infusion solutions directly into the electrospray ionization (ESI)
source. The infusion solutions contained a concentration of 10 µg/mL of each analyte. The results are
shown in Table 2. Additional mass spectrometry (MS) parameters were optimized to achieve the best
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sensitivity, as follows: Delta EMV, 800 V; gas temperature, 350 ◦C; gas flow, 9 L/min; nebulization
pressure, 20 psi; sheath gas, 50 psi; auxiliary gas, 15 psi; capillary voltage, 5000 V.
Table 2. Optimization MRM transitions of androgens and testosterone -d3 derivative with HMP.
Analyte MRM Transition (m/z) Fragmentation Voltage CE (V)
T-HMP 394 > 108 130 40
T-d3-HMP 397 > 108 200 50
EPI-HMP 394 > 108 210 40
DHEA-HMP 394 > 109 120 35
Collision energy (CE); Voltage (V); testosterone (T); testosterone -d3 (T-d3); epitestosterone (EPI); dihydroepianderston
(DHEA); 2-Hydrazino-1-methylpyridine derivative (HMP); multiple reaction monitoring (MRM).
2.4. Experimental Design
To investigate the effect of exercise on endogenous androgens in saliva using an optimised and
validated method, saliva was collected from 20 young male professional soccer players (20.6 ± 1.4
years, body mass 70.2 ± 1.6 kg, height 178 ± 2 cm and Body mass index (BMI) 20.6 ± 1.4 kg/m2)
using a Sarstedt Salivette polyester. The samples (pre-post) were collected over two days during the
training sessions. No participant was injured, and no participant took any medication during the study.
The participants attended the club one and a half hours before training starts every day. The study was
approved by the Ethics Committee at King Saud University, and all players read the information sheet
and signed a consent form before participating in the study.
All training sessions started at the same time each day. Two training sessions were designed for
the study, beginning with a 15 min warm up. Then, the players were divided randomly to play two
small side games for 30 min, followed with 4 min rest time. In addition, the coach set up a game for
40 min divided into two halves, followed with a 5 to 10 min cool down period. The intensity on the
first training day and the second day was designed based on the percentage of the maximum heart
rate. The heart rates were 70% and 72% of the maximum on the first and second days, respectively.
The mean ambient temperature was 25 ± 3 ◦C, and the humidity was 18 ± 4% for the first day and
26 ± 1 ◦C and 16 ± 2% for the second day.
2.5. Pre-Treatment and Extraction of Samples
The stored samples were thawed and then centrifuged at 1000× g for 5 min, and 0.5 mL of
supernatant was taken. The saliva samples were deprotonated with 0.5 mL of acetonitrile containing
50 pg of T-d3, vortexed for 30 s, centrifuged for 10 min and then diluted with water (1.5 mL).
For the extraction, the samples were loaded onto a Strata-XL reverse phase cartridge, which was
first prepared by washing with 1 mL of methanol (MeOH) followed by 1 mL of water (H2O). After
washing with 1 mL of H2O followed by 1 mL of MeOH/H2O (10:90 v/v), the retained analytes and IS
were eluted under gravity with 1 mL of acetonitrile.
2.6. Derivatization of Androgens with 2-Hydrazino-1-Methylpyridine Derivative HMP
The derivatization of the standards (STDs) or extracts with deuterated testosterone (T-d3) was
carried out by adding 50 µL of fresh 2-Hydrazino-1-Methylpyridine Derivative (HMP) solution
(1 mg/mL) in methanol (EtOH0 containing 25 µg of trifluoroacetic acid (TFA). The sample was then
incubated at 50 ◦C for 30 min. The mixture was then gently evaporated under the nitrogen. The residue
was reconstituted using the mobile phase (200 µL) and then vortexed. Finally, 10 µL of the mixture
was injected.
2.7. Method Validation
The method was validated according to the Food and Drug Administration guidelines (FDA) [34].
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2.7.1. Extraction Recovery
Two sets of standards were prepared, each of which contained 50, 200 and 400 pg, corresponding
to 100, 400 and 800 pg/mL of testosterone (T), dehydroepiandrosterone (DHEA)and epitestosterone
(EPI), respectively. One set was made in the pooled steroid-free saliva samples (blank), and the other
set was prepared in the mobile phase. The blank saliva samples (500 µL) were spiked with these
three concentrations in triplicate and then extracted. The saliva samples were mixed with 100 pg of a
deuterated testosterone (T-d3), referring to 200 pg/mL. The standards of the other set were directly
injected after theywere combinedwith an internal standard and then derivatized (i.e., the non-extracted
samples). The peak area means of T, DHEA and EPI and the (T-d3) were obtained for the extracted and
non-extracted samples in each concentration. The absolute recovery was determined for each analyte
by dividing the average extracted mean by that of the non-extracted mean at the same level and then
multiplying by 100 [16].
2.7.2. Matrix Effect
The matrix effect refers to any compound in the sample except the analyte of interest, which
could affect the analyte response when co-eluted with it, causing an increase in ionization efficiency
(i.e., enhancement) or a decrease in ionization efficiency (i.e., suppression). The consequence is an
inaccurate concentration measurement. [35].
Two sets of samples were prepared in low (50 pg), medium (100 pg), and high (400 pg)
concentrations of standards and deuterated testosterone (T-d3), corresponding to 100, 200 and
800 pg/mL each. Set one consisted of derivative standards that were injected six times to establish a
mean peak area for each concentration. Set two involved three different pooled blank saliva samples
from ten sources. Each matrix source was extracted in duplicate, and the extract was spiked in either
the low, medium or high concentrations of standards and T-d3. The matrix effect was then calculated
by averaging the area of each, as shown in Equation (1) [35]:
% ionisation enhancement or suppression = ((X Area o f set2−X Area o f set1)/X Area o f set1) ∗ 100 (1)
A negative value indicates signal suppression, whereas positive values suggested that enhancement
occurred. The acceptable limits for enhancement or suppression are ±25% [35].
2.7.3. Specificity
In the actual method, to ensure that no interference occurred between each analyte of interest by
internal standard or other substances during their retention time in the saliva, three representative
types of steroids, pregnenolone, dihydrotestosterone and androstenedione, were derivatized at 800
pg/mL and injected into the mass spectrometry (MS) system.
2.7.4. Linearity and Calibration Standards of the Saliva
Pooled saliva samples were prepared, and the samples were mixed for 24 h with 1 g of
activated charcoal (NoritEXW, Nacalai Tesque, France) and then centrifuged at 1000× g for 20 min.
The supernatant was examined to ensure that no testosterone (T), dehydroepiandrosterone (DHEA) or
epitestosterone (EPI) was detected following this treatment. Aliquots of steroid-free saliva samples
(blank saliva) (0.5 mL) were spiked with standards (STDs) to prepare six different concentrations of
these steroids in the range of 10–400 pg, corresponding to 20–800 pg/mL of DHEA and T; and in the
range of 25–600 pg, corresponding to 50–1200 pg/mL of EPI. The level of the internal standard (T-d3)
was 100 pg/mL. After evaporation, the residue was dissolved in 200 µL of ethanol and then derivatized
with the HMP reagent using the final optimised procedure described above. The calibration curves
were determined by plotting the peak area ratio of T/T-d3, DHEA/T-d3 and EPI/T-d3 (y) against the
concentrations of T, DHEA and EPI (x, pg/mL), respectively.
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2.7.5. Sensitivity: Limit of Detection (LOD) and Limit of Quantification (LOQ)
Stock solutions of testosterone (T) and dehydroepiandrosterone (DHEA) were prepared at
concentrations of 10–400 pg/0.5 mL, equal to 20–800 pg/mL. Meanwhile, epitestosterone (EPI) was
prepared at concentrations of 25–600 pg/0.5 mL, equal to 50–1200 pg/mL. They were then spiked
into the blank saliva and analyzed in triplicate following derivatization. The LOD and LOQ of T,
DHEA and EPI were determined using a linear calibration curve [34]. Three calibration curves were
constructed. The LOD and LOQ were calculated according to an estimate from the standard deviation
of the y-intercept (Sy) and the average slope (Am), as shown in Equation 2.
LOD = 3 * Sy /Am
LOQ = 10* Sy /Am
(2)
2.7.6. Accuracy and Precision
The accuracy of the results was determined by calculating the percentage recovery of five
determinations at three different concentrations obtained from five sources in a linearity range of 50,
400 and 800 pg/mL. The concentrations were calculated from the corresponding regression equations.
Precision was performed for three different concentrations of pure standards of steroids (50,
400 and 800 pg/mL for testosterone (T), dehydroepiandrosterone (DHEA) and epitestosterone (EPI)„
respectively) spiked into the saliva. They were analyzed in triplicate in a single day and on five
following days to calculate the intra-day (i.e., repeatability) and inter-day precision (i.e., intermediate
precision).
2.7.7. Stability
Two terms were investigated to study the stability of the analytes. In the short-term study, 0.5 mL
of the blank saliva samples was spiked with low and high concentrations of the analytes (50 and
400 pg) and deuterated testosterone (T-d3) (50 pg), corresponding to 100 and 800 pg/mL each, as well as
100 pg/mL for the T-d3, before being stored at different temperatures (4, −20
◦C and in the auto-sampler)
and then analyzed after thawing and extraction. Regarding the freeze-thaw stability, two cycles in
the short-term study were assessed in triplicate after 24 h and 48 h. In addition, the low and high
concentrations of the analytes (100 and 800 pg/mL) and T-d3 (100 pg/mL) were stored at −20
◦C for
six weeks and then analyzed after more than three freeze-thaw cycles. In the long-term evaluation,
24 random samples were chosen from the overall samples, analyzed and then stored at −80 ◦C for
six weeks, and then rerun. The first run of each concentration in the short or long-term study was
considered a time-zero response. Thus, the stability was satisfactory if the response was within 15% of
the time zero response.
3. Results and Discussion
3.1. Optimization of Reaction Conditions in Derivatization Steroids with HMP
Two isomeric (E &Z) peaks were formed, as a result of reacting the 2-Hydrazino-1-Methylpyridine
(HMP) derivatization reagent with testosterone (T) and epitestosterone (EPI0. In contrast,
dehydroepiandrosterone (DHEA-HMP) formed just one peak (possibly due to a steric hindrance from
the methyl group at the 18 position in the steroid nucleus inhibiting the formation of the syn isomer).
It was found that the evaporation step was crucial since only 2% of the steroid was derivatized
without evaporation, while 99% was derivatized when the solvent was evaporated with nitrogen gas.
Shou et al. [36] justified this increase, reporting that when using trifluoroacetic acid (TFA )as a catalyst,
it has the power to form ion pairs, which leads to the prevention and loss of the electrospray ionization
(ESI) signal. To overcome this problem, nitrogen evaporation was used to dry the sample, which led to
improved results.
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The reaction times of 30 min and 1, 2, 4 and 24 h were used with two temperatures (room
temperature and 50 ◦C). The results are shown in Figure S2 and indicate that the highest reaction
efficiency between the androgens and HMP occurred after 30 min of incubation at both room
temperature and 50 ◦C. However, when the androgens were heated at 50 ◦C, the derivatization was
complete within 30 min (99.8%). Therefore, it was concluded that heating at 50 ◦C for 30 min yielded
the best result.
3.2. Optimization of LC Conditions
Three columns were examined to determine their efficiency in separating the steroids. This testing
involved an ACE 3 C18 column (150 × 3.0 mm i.d.; Hichrom, Reading, UK), an ACE 5 C18-AR
column (150 × 4.6 mm, 5 µmHichrom) and an ACE Ultracore 2.5 Superphenylhexyl (150 × 3.0 mm id.;
Hichrom). The C18 column did not provide any acceptable separation between the steroid derivatives.
The C18-AR gave only a poor separation between the dehydroepiandrosterone (DHEA-HMP) peak
and the first peak of testosterone (T-HMP), which led to co-elution. Because it was not possible to
achieve an acceptable separation between the first peak of T-HMP and DHEA-HMP by using the
C18-AR column, an ACE Ultracore 2.5 Superphenylhexyl column (150 × 3.0 mm id) was used and
produced an adequate separation of the steroids. All the analyte peaks appeared within the range of
5.6 to 15 min (Figure 1), using the conditions described in Section 2.3.1; on the other hand, because of
the presence of twin peaks for T-HMP and EPI-HMP (Figure S1), and since the second eluting isomers
gave higher abundances, they were used for the quantification.

Figure 1. Chromatograms of HMP derivatives of testosterone (T-HMP), dehydroepiandrosterone
(DHEA-HMP), epitestosterone (EPI-HMP) and Testosterone-d3 HMP (T-d3-HMP) in healthy human
saliva spiked after treatment with activated charcoal: (A) chromatographic resolution of derivative
testosterone (T), dehydroepiandrosterone (DHEA) and epitestosterone (EPI), (400 pg/mL) spiked
in steroid free saliva. (B) T-HMP multiple reaction monitoring (MRM) illustrating low limit of
quantification (LOQ) m/z 394 > 108, (20 pg/mL); (C) DHEA-HMP limit of quantification (LOQ) m/z
394 > 109, (20 pg/mL); (D) EPI-HMP limit of quantification (LOQ) m/z 394 > 108, (50 pg/mL); (E)
Testosterone-d3 HMP m/z 397> 108, (100 pg/mL); (F) Blank: saliva treated with activated charcoal,
before being extracted and derivatized. The liquid chromatography-mass spectrometry (LC-MS/MS)
conditions are described in Section 2.3.2. Counts per second (cps).
3.3. Optimization of MS Conditions
The parameters of the mass spectrometer (MS) operating conditions are provided in Table 3.
The optimal MS parameters were achieved by the direct infusion of the derivatives of the steroids
into the electrospray ionization (ESI) source in the positive mode. The infusion solution consisted of
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50/50 (v/v) of aqueous and organic mobile phases at a concentration of 10 µg/mL for all the analytes.
The optimal MS transitions had only one product ion with the chosen collision energy, as follows: m/z
394 > m/z 108; m/z 394 > m/z 109; m/z 394 > m/z 108; and m/z 397 > m/z 108, for testosterone (T-HMP),
dehydroepiandrosterone (DHEA-HMP), epitestosterone (EPI-HMP) and deuterated testosterone
(T-d3-HMP), respectively, as described in Section 2.3.2 (Table 2). The product ion is formed by the
cleavage of the N-N bond of the hydrazine, as shown in Figure S1; the derivatization of the T and EPI
with HMP results in hydrazones with just a fragmentation ion [M]+, whereas DHEA-HMP gave a
fragmentation ion with [M + 1]+.
Table 3. Summary of the optimum conditions for ion source parameters.
Parameter Ranges The Optimum Conditions
Delta 400–600–800 800
Gas temperature 300–325–350 ◦C 350 ◦C
Gas flow 8–9–10–11 L/min 9 L/min
Nebulization pressure 15–20–25–30 psi 20 psi
3.4. Collection of Saliva and Pre-Treatment
There are many ways to collect saliva; the most popular method is by passive drool, or spitting,
as mentioned in Table 1. Saliva collection can be stimulated by chewing gum or citric acid, which
could cause a reduction of the analyte concentration [37]. Also, the collection of Salina testosterone
(Sal-T) and other steroids, using different devices such as Salivette® (Sarstedt) with cotton, polyester
and polyethylene, were evaluated. The polyester and polyethylene Salivette have been given weak
recovery for androgen. On the other hand, Salivette® cotton is not recommended [38,39]. Polyester
Salivette was used for the collection of saliva samples in this project. Therefore, the evaluation of
recovery from this device has been made and was compared with the direct collection by collecting a
sample from a participant 5 times for both collection types following the collection protocol. Recoveries
were compared and calculated by using an independent t-test. The results for the recovery of Sal-T
using the Salivette device in comparison to the direct collection was 86%, and the p-value was 0.1,
whereas the saliva dehydroepiandrosterone (Sal-DHEA) recovery was 83.5% and the p-value was 0.2.
3.5. Solid Phase Extraction Cartridge Selection
Two kinds of cartridges (C18-E and Strata-XL polymeric reverse phase) were examined. After
suitable sorbents for the analytes were chosen, the 10-bottle optimization SPE extraction approach,
which is recommended by the Agilent company, was applied [40]. The optimization was started using
a procedure where 11 cartridges from each sorbent were conditioned with 1 mL methanol followed by
1 mL of water (H2O). Then, 100 µL of ethanol containing 100 pg of standards (STDs) were added to
1 mL H2O and loaded on 10 cartridges of each sorbent. Only 1 mL H2O without any STDs was loaded
on the blank number 11 for each sorbent. Figure S3C shows that 10% to 20% of methanol (MeOH) and
80% to 90% of H2O could be used in the washing step because of the low quantity of steroids that was
lost from both cartridges.
As shown in Figure S3A,B, 1 mL of acetonitrile () yielded the highest extraction recovery for all
the steroids. Overall the Strata-XL cartridge gave a slightly better performance. Therefore, the final
extraction procedure used to extract the steroids from the saliva samples was as follows: the sample
was loaded onto the Strata-XL cartridge, which was prewashed with 1 mL of MeOH followed by 1 mL
of H2O. After washing with 1 mL H2O followed by MeOH: H2O (10:90 v/v), the target analytes were
eluted with 1 mL of ACN.
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3.6. Method Validation
3.6.1. Extraction Recovery from Spiked Human Saliva
The efficiency of the extraction procedure of testosterone (T), dehydroepiandrosterone (DHEA)
and epitestosterone (EPI) using solid phase extraction cartridge (SPE) was assessed by calculating the
extraction recovery percentages. The extraction method was able to extract more than 93% of T, more
than 86% of DHEA, and more than 96% of EPI in three different concentrations, as shown in Table 4.
Table 4. Extraction Recovery Data on Androgens Determined in Saliva Using LC-MS/MS.
Compounds
Concentration
(pg/mL)
Level
Average Ratio Extraction
RecoveryExtracted Non-Extracted
n = 3 Mean ± S.D. * Mean± S.D. * (%)
T
100 Low 7037 ± 416 6650 ± 197 105.8
400 Medium 21,797 ± 766 21,590 ± 1569 101.0
800 High 56,725 ± 2196 63,539 ± 5556 89.3
DHEA
100 Low 5072 ± 207 4880 ± 532 103.9
400 Medium 21,760 ± 1214 23,187 ± 1181 93.8
800 High 48,749 ± 1297 52,424 ± 4102 93.0
EPI
100 Low 3853 ± 233 3828 ± 261 100.7
400 Medium 12,629 ± 745 12,420 ± 119 101.7
800 High 23,231 ± 1872 23,424 ± 2244 99.2
T-d3 200 IS 7727 ± 882 8720 ± 883 112.8
(*) Expressed as standard deviation (S.D.); testosterone(T), dehydroepiandrosterone, (DHEA) and epitestosterone
(EPI).
3.6.2. Matrix Effects
As shown in Figure S4, thematrix slightly enhanced the response for all steroids and the deuterated
testosterone (T-d3) in the low and medium concentrations, whereas at the highest level the signal was
slightly suppressed. The matrix effect was within the range of ±25%, which was acceptable.
3.6.3. Specificity
The specificity was determined using the liquid chromatography-mass spectrometry (LC-MS-MS)
conditions described in Section 2.3.2. Three steroids, pregnenolone, dihydrotestosterone and
androstenedione, were investigated to determine the most productive ion, and the retention time
was as follows: pregnenolone (PREG) m/z 422.5 [M]+, m/z 108.0 and retention time 7.3 and
11.5; 5α dihydrotestosterone (DHT) m/z 396.2 [M]+, m/z 108.0 and retention time 7.5 and 11.8;
and androstenedione (AD) m/z,497.4 [M − 1]+, m/z 108.0 and retention time 7.3 and 11.5 min, all of
which had twin peaks. All these steroids were not detected by the multiple reaction monitoring
(MRM)conditions used for testosterone (T), dehydroepiandrosterone (DHEA) and epitestosterone
(EPI), that derivatized by 2-Hydrazino-1-Methylpyridine Derivative (HMP) when 800 pg/mL of the
potentially interfering steroids were injected.
3.6.4. Linearity and Calibration of Standards Spiked into Saliva
The assay showed that the linearity was acceptable within the range of 10–400 pg corresponding
respectively to 20–800 pg/mL for testosterone (T) and dehydroepiandrosterone (DHEA); and within
the range of 25–600 pg corresponding respectively to 50–1200 pg/mL for epitestosterone (EPI), with
correlation coefficients of ≥0.995 (Figure S5A,B). In addition, reliable resolution of the peaks and
acceptable peak shapes were achieved for T, DHEA, EPI and deuterated testosterone (T-d3). The ratios
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obtained for DHEA and T against the (T-d3) were roughly equal; therefore, some points in the calibration
curve appear as one point.
3.6.5. Sensitivity: Limit of Detection (LOD) and Limit of Quantification (LOQ)
As summarized in Table 5, LLOQ and LOD were calculated for testosterone (T) and
dehydroepiandrosterone (DHEA) at concentrations of 20–800 pg/mL, and epitestosterone (EPI) at
concentrations of 50–1200 pg/mL. The LOQ was 20 pg/mL for T and DHEA and 50 pg/mL for EPI.
However, the LODs for T, DHEA and EPI were 4, 6 and 14 pg/mL, respectively.
Table 5. Calibration Curve Parameters (n = 3).
Analyte
LOD
pg/mL
LLOQ
pg/mL
Slope Intercept r
Mean S.D. RSD Mean S.D. Mean
T 4 20 0.0337 0.000954 2.83068 0.280067 0.016757 0.9978
DHEA 6 20 0.034333 0.000551 1.60414 0.224933 0.023755 0.9996
EPI 14 50 0.0186 0.000173 0.93121 0.326333 0.041834 0.995
3.6.6. Accuracy and Precision
The method was shown to be reproducible regarding the peak shape and retention time.
The relative standard deviation (RSD%) of the intra- and inter-assay precision for testosterone
(T), dehydroepiandrosterone (DHEA) and epitestosterone (EPI) was <11%. The accuracy was within
the range of 93–114%. The results for the accuracy and precision of the method are shown in Table 6.
Table 6. Intra-and Inter-Assay Precision and Accuracy Results of Androgen Determination in Saliva
Using LC-MS/MS (n = 5).
Analyte Concentration Level Intra-Day Inter-Day
(pg/mL)
RSD a
(%)
Mean
(pg/mL)
Accuracy b
RSD a
(%)
Mean
(pg/mL)
Accuracy b
T
50 Low 6.8 46.8 93.5 9.9 47.0 93.9
400 Medium 5.9 401 100.5 4.1 409.8 102.4
800 High 3.0 816 102.0 5.5 760.4 95.1
DHEA
50 Low 4.1 51.2 102.4 8.6 57.2 114.5
400 Medium 1.8 405.0 102.5 10.8 398.4 99.6
800 High 2.3 795.8 99.5 7.4 784.8 98.1
EPI
50 Low 8.9 49.8 99.6 9.9 47.0 93.9
400 Medium 3.4 427.8 106.9 4.1 409.8 102.4
800 High 4.7 731.4 91.4 5.5 760.4 95.0
a expressed as the relative standard deviation (RSD). b expressed as [mean % deviation = mean calculated
concentration/nominal concentration X100].
3.6.7. Stability
Table 7 shows that after two cycles of freezing/ thawing at two different temperatures
and on auto-sampler, there was the satisfactory stability of the analytes (testosterone (T),
dehydroepiandrosterone (DHEA) and epitestosterone (EPI)) during the short term (24 and 48 h).
However, there were slight decreases from zero-response in the auto-sampler. In contrast, the
degradation of the analytes in low and high concentrations of 100 and 800 pg/mL, respectively, and the
deuterated testosterone (T-d3) in a concentration of 100 pg/mL, was >50% when they were stored for
six weeks at −20 ◦C after freezing/thawing for a third cycle. The stability of the derivative steroids
was acceptable in 24 samples that were reanalyzed after being stored at −80 ◦C for six weeks. When
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the samples were rerun, the percentages compared with the original response were 95% and 97% for
testosterone (T) and dehydroepiandrosterone (DHEA), respectively.
Table 7. Stability of T, DHEA and EPI in the short term.
Treatment T a DHEA a EPI a
100 800 100 800 100 800
Freezing/thawing,
1 cycle
−20 ◦C 100.1 ± 9.1 98.0 ± 1.7 100.1 ± 0.1 97.1 ± 1.8 98.0 ± 0.5 97.2 ± 5.7
4 ◦C 98.1 ± 3.9 97.2 ± 0.6 96.4 ± 0.6 96.7 ± 1.6 94.8 ± 2.3 95.2 ± 5.1
Auto-sampler 97.0 ± 2.2 96.9 ± 3.2 95.1 ± 1.0 95.7 ± 1.4 95.7 ± 0.8 92.5 ± 3.3
Freezing/thawing,
2 cycles
−20 ◦C 97.2 ± 4.0 98.7 ± 0.0 99.8 ± 2.3 96.9 ± 2.3 94.4 ± 3.1 95.7 ± 2.2
4 ◦C 98.1 ± 2.6 95.7 ± 3.3 96.7 ± 5.7 97.3 ± 4.9 92.8 ± 2.7 93.5 ± 0.1
Auto-sampler 93.8 ± 1.6 94.6 ± 6.4 95.5 ± 1.8 92.3 ± 1.0 94.8 ± 5.5 91.4 ± 6.5
a expressed as mean% ± S.D. of triplicate runs.
4. Method Application
Exogenous androgens in saliva samples were determined in twenty professional soccer players.
All players attended the training sessions during the mid-season; the players train 90 min a day over
five days a week, and they play one match per week. The samples were collected over two days before
and after the training sessions.
The protocol of the injection sample in liquid chromatography-mass spectrometry (LC-MS-MS)
was as follows: four samples belonging to each player, pre- and post-exercise, were injected
sequentially on subsequent days. Seven pooled samples were prepared randomly from overall
samples to examine technical variations. The results showed that the average of testosterone (T)
and dehydroepiandrosterone (DHEA) levels in the pooled samples were 226.2 pg/mL ± 5.7% and
40.7 pg/mL ± 8.7%, respectively.
A paired t-test was used for the statistical comparison of the variables (T and DHEA) both pre-
and post-exercise. The post-exercise DHEA levels increased significantly (mean = 397.45 pg/mL) by
about 105 pg/mL (p-value = 0.008) compared to the pre-exercise level mean = 292.50 pg/mL. However,
there was no significant change in the T levels between the post-exercise mean = 84.35 pg/mL and
pre-exercise mean = 84.85 pg/mL. We compared the mean level of T in pre and post-exercise in the
current study with a Japanese study [9]. They mentioned that between 20 to 30 years, for healthy men,
the mean level of saliva testosterone (Sal-T) was high in the morning (rough mean= 55.0 pg/mL) while
in the current study 84.35 pg/mL was obtained. The collection saliva in the current study was in the
afternoon time and was also from very fit subjects. The greater T level in the current study could be
due to the long term impact of physical activity, which is in agreement with other studies [13,41]. In the
present study, T levels do not reveal any significant differences based on player positions (Figure 2A),
and that may be because training sessions were considered as having a moderate intensity based on
the percentage of the heart rate of the maximum heart beats. On the other hand, in Australian football
players, they found that the T levels increased in all positions, but the performance was increased just
in midfielder players, who have a higher training load than other positions [13].
ANOVA was used to compare the differences in DHEA for three positions (defender, midfielder
and attacker). The results showed no specific differences in any of the positions between pre- and
post-exercise. The Body mass index (BMI) and age were not compared because of small variations in
both ranges. The comparison was performed using a one-way ANOVA (Figure 2B).
Previous studies have found that the highest levels of DHEA and T occurred in the early morning,
which then decreased gradually during the day [9]. The current results indicated that brief, intense
physical activity could significantly increase DHEA, which could lead to improved well-being and
protection from many diseases [4].
Sci. Pharm. 2019, 87, 11 13 of 16


Figure 2. Pre- and post-exercise rhythms of (A) Sal-T levels and (B) Sal-DHEA levels in 20 young
professional soccer players in three different positions.
To study the correlation between the level of saliva dehydroepiandrosterone (Sal-DHEA) and
–T (n = 20), a Pearson correlation was calculated, and the result (Figure S6A,B) indicated that there
was no correlation between them in pre or post-exercise since the Pearson correlation R2 and p-values
were 0.014, 0.0002 and 0.935 for pre, and 0.407, 0.166 and 0.075 for post-training. T can be formed from
DHEA via androstenedione or androst-5-ene-3β,17β-diol, and it might be that the build-up of DHEA
leads to increased testosterone after a longer period of post-training. Epitestosterone was not detected
in any of the collected samples.
5. Conclusions
The development of a derivatization method for exogenous androgens in a saliva sample
followed by analysis by using liquid chromatography-mass spectrometry (LC-MS-MS) was achieved.
The 2-Hydrazino-1-Methylpyridine Derivative (HMP) reagent was chosen for the derivatization,
and the reaction conditions were optimized. The optimization of the derivatization involved several
steps, including the ratio temperature and incubation time. The acceptable separation between these
analytes was achieved by using an ACE Ultracore 2.5 Superphenylhexyl column.
A rapid procedure for the extraction of the steroids from the saliva sampleswas developed by using
a polymeric reverse solid phase extraction cartridge (SPE). testosterone (T) and dehydroepiandrosterone
(DHEA) were extracted from the saliva, and an LC-ESI-MS/MS method for detecting the steroids in the
saliva sample was developed, and the process was validated according to FDA guidelines and had
acceptable specificity, sensitivity, predictability, repeatability and accuracy.
This method was applied to the analysis of saliva samples collected from football players pre-and
post-training over two days. The concentrations T and DHEA in the saliva samples were determined,
whereas epitestosterone (EPI) was not detected. The levels of saliva testosterone (Sal-T) detected in
the pre-and post-exercise samples showed no significant difference in Sal-T before and after training.
However, the saliva dehydroepiandrosterone (Sal-DHEA) level registered a considerable difference.
The correlation between the level of Sal-T and Sal-DHEA in the pre-exercise or the post-exercise samples
was not high, suggesting no change in activity for the enzymes responsible for producing T from
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DHEA. However, the number of subjects was relatively small and it might be that a different outcome
would be achieved with a larger sample size. Since the analytical method works effectively and has
been shown to be stable, it would be possible to use the method to analyze samples from different
cohorts of subjects undergoing different types of physical activity, e.g., ultramarathon runners [42].
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/2218-0532/87/2/11/s1,
Figure S1: Structures of derivatization 2-Hydrazino-1-methylpyridine derivative (HMP) with testosterone,
dehydroepiandrosterone and epitestosterone; Figure S2: Optimization of reaction conditions in derivatization
steroids with HMP; Figure S3: Solid phase extraction cartridge selection.; Figure S4: Matrix Effect; Figure S5:
Linearity and calibration of standards spiked into saliva; Figure S6: Correlation between the concentrations of
Sal-DHEA and Sal-T (n = 20) were (A) pre-training and (B) post-training.
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